Continuously improving patient outcomes with previously unavailable insights. Find out more here.
Location: Belgium, Flemish Brabant, Leuven
Total raised: $23.09M
Investors 5
| Date | Name | Website |
| - | Matterwave... | matterwave... |
| - | b2venture | b2venture.... |
| - | Heran Part... | heranpartn... |
| - | Caring Ent... | caring-ent... |
| 22.06.2022 | Elaia Part... | elaia.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.06.2022 | Series A | $21.1M | - |
| 29.01.2020 | - | $1.99M | Heran Part... |
Mentions in press and media 7
| Date | Title | Description |
| 20.06.2024 | LynxCare appoints Jeanne Kehren to new CEO | Georges’ contributions have been foundational in establishing LynxCare as a leader in harnessing technologies to create healthcare data solutions. As LynxCare continues to grow, the company recognizes the importance of bringing in specializ... |
| 11.10.2022 | LynxCare & Amaron: Unlocking and securing hospital data with the aim of improving patient care | LYNXCARE COUNTS ON AMARON FOR SECURE AND EFFICIENT DATA ACCESS |
| 21.06.2022 | Belgian health tech Lynxcare unlocks €20 million to boost clinical insights for doctors | Belgian AI-powered clinical data platform LynxCare has raised €20 million in funding to accelerate the international rollout of its technology. The Series A investment was led by Swiss healthtech investor MTIP and joined by Elaia and the co... |
| 29.01.2020 | Belgian big data startup LynxCare raises €1.8 million to help healthcare industry | LynxCare, the Leuven-based big data startup working in healthcare, has raised €1.8 million, led by btov Partners with support from existing investor, HERAN Partners. This round follows a €1.75 million raise last April, and will fuel Europea... |
| 20.09.2018 | Meet the startups in the latest Alchemist class | Alchemist is the Valley’s premiere enterprise accelerator and every season they feature a group of promising startups. They are also trying something new this year: they’re putting a reserve button next to each company, allowing angels to e... |
| - | Why 2021 is the right time to scale managed entry agreements | By Nathan Sigworth As we understand more about the science of cancer, we are seeing new innovative treatments coming out of R&D pipelines. These new drugs attack cancer through one mechanism of action, or another, or multiple. With ever... |
| - | Belgian health tech Lynxcare unlocks €20 million to boost clinical insights for doctors | Belgian AI-powered clinical data platform LynxCare has raised €20 million in funding to accelerate the international rollout of its technology. The Series A investment was led by Swiss healthtech investor MTIP and joined by Elaia and the co... |